Treat-to-target trial of basal insulin in Post-Transplant Hyperglycemia (TIP): Efficacy and safety of a novel protocol in renal transplant recipients receiving a tacrolimus-based immunosupprerssion - TIP
Phase 1
- Conditions
- The medical condition to be investigated is post-transplant hyperglycemia in renal transplant recipients.
- Registration Number
- EUCTR2008-005951-84-AT
- Lead Sponsor
- Medizinische Universität Wien, KIM III, Abteilung für Nephrologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Renal transplantation and immunosuppression with the standard protocol of our center (tacrolimus, mycophenolate mofetil, prednisone triple therapy without any induction therapy)
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Any history of Diabetes Mellitus is an exclusion criterion.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method